Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $542 - $788
-4 Reduced 0.56%
711 $109,000
Q4 2022

Feb 07, 2023

SELL
$118.38 - $210.04 $236 - $420
-2 Reduced 0.28%
715 $128,000
Q2 2022

Aug 12, 2022

BUY
$117.13 - $176.59 $75,197 - $113,370
642 Added 856.0%
717 $102,000
Q1 2022

Apr 08, 2022

BUY
$126.46 - $235.05 $9,484 - $17,628
75 New
75 $13,000
Q4 2021

Mar 30, 2022

SELL
$225.82 - $368.51 $33,873 - $55,276
-150 Closed
0 $0
Q3 2021

Nov 03, 2021

BUY
$221.9 - $484.47 $33,285 - $72,670
150 New
150 $57,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Us Asset Management LLC Portfolio

Follow Us Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Us Asset Management LLC with notifications on news.